Flagship Pioneering as of Sept. 30, 2019
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 10 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Rubius Therapeutics | 51.5 | $627M | 38M | 16.38 | |
| Kaleido Biosciences Ord (KLDO) | 10.7 | $131M | 17M | 7.53 | |
| Denali Therapeutics (DNLI) | 10.1 | $123M | 8.0M | 15.32 | |
| Evelo Biosciences | 9.1 | $111M | 18M | 6.10 | |
| Seres Therapeutics | 7.1 | $87M | 22M | 4.01 | |
| Transmedics Group (TMDX) | 4.9 | $60M | 2.5M | 23.75 | |
| Axcella Health Inc equity | 4.1 | $50M | 8.7M | 5.66 | |
| Syros Pharmaceuticals | 2.5 | $31M | 2.9M | 10.38 | |
| Quanterix Ord (QTRX) | 0.0 | $0 | 0 | 0.00 | |
| Moderna (MRNA) | 0.0 | $0 | 59M | 0.00 |
